包装 | 价格(元) |
100mg | 电议 |
250mg | 电议 |
500mg | 电议 |
生物活性 | Surzebiclimab (BGB-A425) is a humanized IgG1-variant monoclonal antibody againstT-cell immunoglobulin and mucin-domain containing-3 (TIM-3). Surzebiclimab binds to the extracellular domain of human Tim-3 with high affinity (KD=0.36 nM) and specificity. Surzebiclimab can be used in research ofcancer[1]. |
体外研究 (In Vitro) | Surzebiclimab (BGB-A425; 0.1-100 μg/mL) 有效阻断 Tim-3 和 PtdSer 之间的相互作用。Surzebiclimab 增强原代 T 细胞的 IFN-γ 产生和 NK 介导的对肿瘤细胞的细胞毒性[1]。 |
体内研究 (In Vivo) | surzebiclimb (BGB-A425) 联合 BGB-A317 在小鼠异种移植瘤模型中抑制肿瘤生长[1]。 |
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |